 Omentin-1 is a novel adipokine with anti-inflammatory properties that has been shown to be elevated in critically ill patients with sepsis. In this study, researchers found that serum omentin-1 levels were higher in patients with sepsis compared to healthy controls, and that these levels continued to increase over time. Additionally, higher levels of omentin-1 were associated with worse outcomes, such as higher mortality rates. This suggests that omentin-1 could serve as a potential biomarker for sepsis. This article was authored by Irene Karampila, Natalia G. Valina, Demetrius Cylangiris, and others.